Insights
Product updates from Medicup, plus healthcare technology news curated from trusted outlets — CDC, FDA, and leading health-tech publications.
The Department of Veterans Affairs has deployed its new Oracle electronic health record system to three more medical centers, continuing a massive, and often challenging, modernization effort.
A new survey finds that while most Americans want to know when AI is involved in their healthcare, nearly half are completely in the dark. Here's why transparency is key for the future of digital health.
The balance of power in healthcare is shifting. As patients become more active consumers, new digital platforms are changing how we access and manage medications. Here's what this trend means for you.
Two major players in digital health are joining forces, with virtual care provider Sword Health set to acquire the popular wellness app Headspace. Here's what it means for the future of integrated care.
A major new investment in an AI-powered behavioral health platform signals a pivotal moment for digital healthcare, showing how technology can expand access and support for patients and providers alike.
A new AI dictation tool from Suki integrates directly with major EHRs like Epic and Meditech, promising to reduce clinician burnout by accurately transcribing complex medical notes and freeing up doctors to focus on patients.
A new class action lawsuit against smart ring maker Oura is raising critical questions about the accuracy of AI-powered health wearables and what the data really means for your health.
The FDA has authorized a groundbreaking wearable device that continuously tracks both glucose and ketone levels, offering a more complete picture of metabolic health for people with diabetes.
Artificial intelligence promises to make healthcare more efficient, but new guidance urges financial leaders to look past the sales pitch. Here's why smart AI adoption in the back office matters for your care.
New AI software is helping hospitals track controlled substances and prevent staff abuse, but the technology is only as good as the human oversight that supports it.
Two new companies, Sondermind and Limbic, have joined a key FDA pilot program aimed at evaluating digital health devices for treating anxiety and depression, signaling a major step forward for regulated digital therapeutics.
The FDA is taking its first steps toward regulating generative AI in medicine, seeking public feedback on the technology's risks and rewards. This move could shape the future of digital health tools for patients and providers.
